Comparative Efficacy of an Intensified Re-vaccination Scheme for Hepatitis B Virus Infection Among Patients Infected With HIV . (CORE-HIV)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT02003703

Recruitment Status : Completed

First Posted : December 6, 2013

Last Update Posted : January 31, 2019

View this study on Beta.ClinicalTrials.gov

Sponsor:

Collaborators:

Roche Pharma AG

GlaxoSmithKline

Aclin Laboratory

Information provided by (Responsible Party):

Felipe Martinez, Universidad de Valparaiso

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Completed
Actual Primary Completion Date :	June 2018
Actual Study Completion Date :	December 2018

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Vargas JI, Jensen D, Martinez F, Sarmiento V, Peirano F, Acuna P, Provoste F, Bustos V, Cornejo F, Fuster A, Acuna M, Fuster F, Soto S, Estay D, Jensen W, Ahumada R, Arab JP, Soza A, Fuster F. Comparative Efficacy of a High-Dose vs Standard-Dose Hepatitis B Revaccination Schedule Among Patients With HIV: A Randomized Clinical Trial. JAMA Netw Open. 2021 Aug 2;4(8):e2120929. doi: 10.1001/jamanetworkopen.2021.20929.

To Top